5-HT2c/sigma opioid antagonist (EGIS)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name5-HT2c/sigma opioid antagonist (EGIS)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2c (5-HT2c) receptor antagonistsSigma opioid receptor antagonists
TargetsSigma opioid receptorSerotonin 2c (5-HT2c) receptor
Therapy Area/IndicationsStomach Ulcer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryHungary
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEgis Pharmaceuticals PLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEgis Pharmaceuticals PLC
Active IndicationsN/A
Inactive IndicationsStomach Ulcer

Other Information

ATC CodeN/A
Related LinksN/A